MORPHOSYS AND CHIMERA ANNOUNCE COOPERATION AND CO-MARKETING

Antibodies by Design, a Division of MorphoSys AG, Munich, and Chimera Biotec GmbH have announced the start of a co-marketing agreement between the two companies. Within the scope of the agreement the parties agree to co-market generation of monoclonal antibodies by Antibodies by Design and Chimera Biotec's complementary Imperacer assay technology for ultra-sensitive antigen detection.
Genomics and Proteomics